Jason E Ham1, Paul D Siegel1, Howard Maibach2. 1. a Health Effects Laboratory Division , National Institute for Occupational Safety and Health , Morgantown , WV , USA. 2. b Department of Dermatology, School of Medicine , University of California-San Francisco , San Francisco , CA , USA.
Abstract
PURPOSE: Formaldehyde allergic contact dermatitis (ACD) may be due to products with free formaldehyde or formaldehyde-releasing agents; however, assessment of formaldehyde levels in such products is infrequently conducted. The present study quantifies total releasable formaldehyde from "in-use" products associated with formaldehyde ACD and tests the utility of commercially available formaldehyde spot test kits. MATERIALS AND METHODS: Personal care products from 2 patients with ACD to formaldehyde were initially screened at the clinic for formaldehyde using a formaldehyde spot test kit. Formaldehyde positive products were sent to the laboratory for confirmation by gas chromatography-mass spectrometry. In addition, 4 formaldehyde spot test kits were evaluated for potential utility in a clinical setting. RESULTS: Nine of the 10 formaldehyde spot test kit positive products obtained from formaldehyde allergic patients had formaldehyde with total releasable formaldehyde levels ranging from 5.4 to 269.4 µg/g. Of these, only two shampoos tested listed a formaldehyde-releasing agent in the ingredients or product literature. Subsequently, commercially available formaldehyde spot test kits were evaluated in the laboratory for ability to identify formaldehyde in personal care products. CONCLUSIONS: Chemical based formaldehyde spot test were more reliable than the enzymatic based test in identifying product releasable formaldehyde content. It is concluded that product labeled ingredient lists and available information are often inadequate to confirm the potential for formaldehyde exposure and chemical based spot test kits may have utility for identification of potential formaldehyde exposure from personal care products.
PURPOSE:Formaldehyde allergic contact dermatitis (ACD) may be due to products with free formaldehyde or formaldehyde-releasing agents; however, assessment of formaldehyde levels in such products is infrequently conducted. The present study quantifies total releasable formaldehyde from "in-use" products associated with formaldehyde ACD and tests the utility of commercially available formaldehyde spot test kits. MATERIALS AND METHODS: Personal care products from 2 patients with ACD to formaldehyde were initially screened at the clinic for formaldehyde using a formaldehyde spot test kit. Formaldehyde positive products were sent to the laboratory for confirmation by gas chromatography-mass spectrometry. In addition, 4 formaldehyde spot test kits were evaluated for potential utility in a clinical setting. RESULTS: Nine of the 10 formaldehyde spot test kit positive products obtained from formaldehydeallergicpatients had formaldehyde with total releasable formaldehyde levels ranging from 5.4 to 269.4 µg/g. Of these, only two shampoos tested listed a formaldehyde-releasing agent in the ingredients or product literature. Subsequently, commercially available formaldehyde spot test kits were evaluated in the laboratory for ability to identify formaldehyde in personal care products. CONCLUSIONS: Chemical based formaldehyde spot test were more reliable than the enzymatic based test in identifying product releasable formaldehyde content. It is concluded that product labeled ingredient lists and available information are often inadequate to confirm the potential for formaldehyde exposure and chemical based spot test kits may have utility for identification of potential formaldehyde exposure from personal care products.
Authors: Amber Reck Atwater; Amy J Petty; Beiyu Liu; Cynthia L Green; Jonathan I Silverberg; Joel G DeKoven; Donald V Belsito; Margo J Reeder; Denis Sasseville; James S Taylor; Howard I Maibach; Matthew J Zirwas; James G Marks; Kathryn A Zug; Joseph F Fowler; Melanie D Pratt; Vincent A DeLeo; Erin M Warshaw Journal: J Am Acad Dermatol Date: 2021-02-09 Impact factor: 15.487
Authors: Yujie Linda Liou; Lindsey M Voller; Walter Liszewski; Marna E Ericson; Paul D Siegel; Erin M Warshaw Journal: Dermatitis Date: 2021 Sep-Oct 01 Impact factor: 4.867
Authors: Rebecca S Kimyon; Lun-Yi Zang; Paul D Siegel; Lindsey M Voller; Jamie P Schlarbaum; Erin M Warshaw Journal: Dermatitis Date: 2021 Jul-Aug 01 Impact factor: 4.867
Authors: Wolfgang Uter; Thomas Werfel; Jean-Pierre Lepoittevin; Ian R White Journal: Int J Environ Res Public Health Date: 2020-04-01 Impact factor: 3.390
Authors: Pamela L Scheinman; Marc Vocanson; Jacob P Thyssen; Jeanne Duus Johansen; Rosemary L Nixon; Kate Dear; Nina C Botto; Johanna Morot; Ari M Goldminz Journal: Nat Rev Dis Primers Date: 2021-05-27 Impact factor: 52.329